Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis

Clinical trial NCT00694642 · COMPLETED

Trial details

NCT number: NCT00694642
Sponsor: Pilar Jimenez Quevedo
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Refractory Angina

Start date: 2008-05-01
Primary completion: 2009-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.